Clinical Trial Update: A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for BIO-11006 in advanced non-small cell lung cancer (Stage IIIB) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer Stage Iiib

Drugs mentioned

• BIO-11006

Snippet

Sponsor: BioMarck Pharmaceuticals, Ltd. | Conditions: Non Small Cell Lung Cancer Stage IIIB | Phase 2 | Status: COMPLETED